Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Breast 1

Conditions

Endometrial Neoplasms 2Breast Neoplasms 2Breast Carcinoma In Situ 2Paget's Disease, Mammary 1Hot Flashes 1Endometrial Adenocarcinoma 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1

Interventions

Paclitaxel 8Doxorubicin 7Cisplatin 7Radiotherapy 4Filgrastim 4Chemotherapy, Adjuvant 3Tamoxifen 2Radiotherapy, Intensity-Modulated 2Observation 2Medroxyprogesterone 2Letrozole 2Ifosfamide 2Gene Expression Profiling 2Carboplatin 2Amifostine 2ridaforolimus 1perifosine 1lenvatinib 1irofulven 1abemaciclib 1X-Rays 1Trabectedin 1Therapeutics 1Taxes 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Adjuvant 1Polymerase Chain Reaction 1Phantoms, Imaging 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Endometrial Neoplasms × Medroxyprogesterone × Clear all
NCT00003179 2013-06-10

Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer

GOG Foundation

Phase 2 Terminated
360 enrolled
Gynecologic

Endometrial Neoplasms

NCT00002920 2012-10-31

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed
313 enrolled
BreastGynecologic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡